Neuphoria Therapeutics Inc. - Common Stock (NEUP) Earnings Date, Estimates & Call Transcripts $5.14 +0.03 (+0.59%) As of 04/17/2025 01:43 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock Neuphoria Therapeutics Inc. - Common Stock Earnings Summary Latest Q2 2025 Earnings DateFeb. 14EstimatedConsensus EPS (Feb. 14) -$2.01 Actual EPS (Feb. 14) -$1.23 Beat By $0.78 Actual Revenue (Feb. 14) $660.00BNeuphoria Therapeutics Inc. - Common Stock released Q2 2025 earnings on February 14, 2025, reporting an EPS of -$1.23, which topped analysts' consensus estimates of -$2.01 by $0.78. Quarterly revenue was reported to be $660 billion. With a trailing EPS of $0.00, Neuphoria Therapeutics Inc. - Common Stock's earnings are expected to decrease next year, from ($1.56) to ($1.85) per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Get Neuphoria Therapeutics Inc. - Common Stock Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neuphoria Therapeutics Inc. - Common Stock and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Neuphoria Therapeutics Inc. - Common Stock Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$2.01-$2.01-$2.01Q3 20251-$0.47-$0.47-$0.47Q4 20251-$1.26-$1.26-$1.2620253-$3.74-$3.74-$3.74Q1 20261-$0.55-$0.55-$0.55Q2 20261-$0.61-$0.61-$0.61Q3 20261-$0.42-$0.42-$0.42Q4 20261-$0.42-$0.42-$0.42FY 20264($2.00)($2.00)($2.00) Neuphoria Therapeutics Inc. - Common Stock Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails2/14/2025Q2 2025-$2.01-$1.23+$0.78-$1.23-$660.00B Neuphoria Therapeutics Inc. - Common Stock Earnings - Frequently Asked Questions When did Neuphoria Therapeutics Inc. - Common Stock announce their last quarterly earnings? Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) last announced its quarterly earning data on Friday, February 14, 2025. Learn more on NEUP's earnings history. Did Neuphoria Therapeutics Inc. - Common Stock beat their earnings estimates last quarter? In the previous quarter, Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) reported ($1.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.01) by $0.78. Learn more on analysts' earnings estimate vs. NEUP's actual earnings. How much revenue does Neuphoria Therapeutics Inc. - Common Stock generate each year? Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) has a recorded annual revenue of $662,715.00. How much profit does Neuphoria Therapeutics Inc. - Common Stock generate each year? Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) has a recorded net income of -$15.49 million. NEUP has generated $0.00 earnings per share over the last four quarters. What is Neuphoria Therapeutics Inc. - Common Stock's EPS forecast for next year? Neuphoria Therapeutics Inc. - Common Stock's earnings are expected to decrease from ($1.56) per share to ($1.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies NRXP Earnings Date LTRN Earnings Date FBRX Earnings Date ELYM Earnings Date SCYX Earnings Date FBLG Earnings Date SPRO Earnings Date INKT Earnings Date ATRA Earnings Date HOWL Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead This page (NASDAQ:NEUP) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuphoria Therapeutics Inc. - Common Stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuphoria Therapeutics Inc. - Common Stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.